Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8385 - 8392 of 11524 results
Three More FSMA Rules Finalized As the Year Comes to a Close
November 16, 2015| Blog| Viewpoint
Columbia Law Review Study of Fee Awards in Securities Class Actions Yields Surprising Results
November 16, 2015| Blog| Viewpoint
Genetic Testing, Genome Sequencing, and the FDA
November 13, 2015| Blog| Viewpoint
After Long Consideration, President Rejects Keystone Pipeline
November 13, 2015| Blog| Viewpoint
FDA Invites Genome Scientists to Come Play in the precision FDA “Sandbox”
November 13, 2015| Alert| Viewpoint
When Transparency Is Not Enough: Class Action Litigation Under California's Transparency in Supply Chains Act
November 12, 2015| Blog| Viewpoint
Court Orders Plaintiffs to Pay Defendants' $13.3 Million Appellate Costs in Lawrence E. Jaffe Pension Plan v. Household International
November 12, 2015| Blog| Viewpoint
News & Press Releases
Mintz Serves as Expert Contributor to Oxford University Report on Climate Regulations
November 13, 2024
Mintz is one of two US law firms invited by Oxford University to serve as an expert pro bono contributor to its Climate Policy Monitor, an annual report on global climate regulations which launched today. Including a granular survey of 30 major countries’ net zero implementation (G20+), the research gives the most detailed view yet of how economic rules align—or not—to climate goals.
Mintz Member Sean Prosser was named to Securities Docket’s 2024 “Enforcement Elite” at its Securities Enforcement Forum this year in DC. The annual list recognizes the “best securities enforcement defense counsel in the industry.”
How the Patent System May Look after Trump's Return
November 6, 2024
Member Peter Snell was quoted by Law360 on changes the patent system may experience following Trump's return to office.